Independent growth Auburn operates as an independently-owned national full line generics wholesaler with direct manufacturer sourcing from 100+ suppliers and NABP-accredited facilities, suggesting strong procurement reliability and potential for expanded product partnerships and exclusive generic offerings.

Strategic markets Serving independent pharmacies across retail, specialty, long-term care, hospitals, and governmental entities indicates broad channel reach; sales opportunities can be pursued by tailoring programs for high-volume buyers in these segments.

Compliance advantage Licensed across the continental US and adherent to LSPediA track-and-trace guidelines, Auburn provides a compliance-friendly path for suppliers needing robust regulatory alignment and traceability in their distribution networks.

Technology footprint Utilizes widely adopted tech such as Hotjar, Google Analytics, and Cloudflare, signaling readiness for data-driven sales tools, targeted marketing, and performance analytics to optimize outreach and customer onboarding.

Financial foothold Revenue in the mid-range of $25M-$50M with a lean employee base (51-200) presents growth potential for scalable partnerships, value-added services, and volume-based incentives aimed at expanding market share in generics distribution.